Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 347.00K | 314.00K | 534.00K | 2.34M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 347.00K | 314.00K | 534.00K | 2.34M | |
| Cost of Revenue | 206.00K | 2.28M | 136.00K | 1.52M | |
| Gross Profit | 141.00K | -1.97M | 398.00K | 826.00K | |
| SG&A Expenses | 1.15M | 1.20M | 1.34M | 1.57M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -27.00K | -- | -- | |
| Total Operating Expenses | 2.45M | 5.28M | 3.15M | 5.56M | |
| Operating Income | -2.11M | -4.97M | -2.61M | -3.22M | |
| Income Before Tax | -1.27M | -5.34M | -3.01M | -1.90M | |
| Income Tax Expenses | -4.00K | 0.00 | 1.00K | -- | |
| Earnings from Continuing Operations | -1.26M | -5.34M | -3.01M | -1.90M | |
| Earnings from Discontinued Operations | -506.00K | -16.00K | -1.67M | -1.09M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -1.00K | 45.00K | 219.00K | 402.00K | |
| Net Income | -1.77M | -5.31M | -4.46M | -2.59M | |
| EBIT | -2.11M | -4.97M | -2.61M | -3.22M | |
| EBITDA | -1.97M | -4.70M | -2.37M | -2.91M | |
| EPS Basic | -0.14 | -0.61 | -0.62 | -0.38 | |
| Normalized Basic EPS | -0.06 | -0.36 | -- | -- | |
| EPS Diluted | -0.14 | -0.61 | -0.62 | -0.38 | |
| Normalized Diluted EPS | -0.06 | -0.36 | -- | -- | |
| Average Basic Shares Outstanding | 12.20M | 8.72M | 7.23M | 6.80M | |
| Average Diluted Shares Outstanding | 12.20M | 8.72M | 7.23M | 6.80M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |